Related Experiment Video
Updated: Mar 21, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
Multifunctional DDX3: dual roles in various cancer development and its related signaling pathways
Luqing Zhao1, Yitao Mao2, Jianhua Zhou3
1Department of Pathology, Xiangya Hospital, Central South UniversityChangsha 410008, Hunan, China; Department of Pathology, School of Basic Medical Science, Xiangya School of Medicine, Central South UniversityChangsha 410013, Hunan, China; Department of Dermatology, Xiangya Hospital, Central South UniversityChangsha 410008, Hunan, China.
Abstract:
DEAD-box RNA helicase 3 (DDX3) is a highly conserved family member of DEAD-box protein, which is a cluster of ATP-dependent and the largest family of RNA helicase. DEAD-box family is characterized by the regulation of ATPase and helicase activities, the modulation of RNA metabolism, and the actors of RNA binding proteins or molecular chaperones to interact with other proteins or RNA. For DDX3, it exerts its multifaceted roles in viral manipulation, stress response, hypoxia, radiation response and apoptosis, and is closely related to cancer development and progression. DDX3 has dual roles in different cancer types and can act as either an oncogene or tumor suppressor gene during cancer progression. In the present review, we mainly provide an overview of current knowledge on dual roles of DDX3 in various types of cancer, including breast cancer, lung cancer, colorectal cancer, hepatocellular carcinoma, oral squamous cell carcinoma, Ewing sarcoma, glioblastoma multiforme and gallbladder carcinoma, and illustrate the regulatory mechanisms for leading these two controversial biological effects. Furthermore, we summarize the essential signaling pathways that DDX3 participated, especially the Wnt/β-catenin signaling and EMT related signaling (TGF-β, Notch, Hedgehog pathways), which are crucial to DDX3 mediated cancer metastasis process. Thoroughly exploring the dual roles of DDX3 in cancer development and the essential signaling pathways it involved, it will help us open new perspectives to develop novel promising targets to elevate therapeutic effects and facilitate the "Personalized medicine" or "Precision medicine" to come into clinic.
Insights
DEAD-box RNA helicase 3 (DDX3) plays dual roles in cancer, acting as an oncogene or tumor suppressor. Understanding DDX3
Area of Science:
- Molecular Biology
- Oncology
- Biochemistry
Background:
- DEAD-box RNA helicase 3 (DDX3) is a key protein involved in RNA metabolism.
- DDX3 has diverse roles in cellular processes including stress response, apoptosis, and viral replication.
- Its involvement in cancer development and progression is increasingly recognized.
Purpose of the Study:
- To review the dual roles of DDX3 in various cancer types.
- To elucidate the regulatory mechanisms underlying DDX3's oncogenic or tumor-suppressive functions.
- To summarize DDX3's involvement in critical cancer signaling pathways.
Main Methods:
- Literature review of studies on DDX3 in cancer.
- Analysis of DDX3's roles in specific cancers (breast, lung, colorectal, etc.).
- Examination of signaling pathways (Wnt/β-catenin, TGF-β, Notch, Hedgehog) associated with DDX3.
Main Results:
- DDX3 exhibits context-dependent dual roles, acting as an oncogene or tumor suppressor in different cancers.
- DDX3 influences cancer metastasis through pathways like Wnt/β-catenin and EMT signaling.
- Specific regulatory mechanisms driving these opposing effects are identified.
Conclusions:
- DDX3's dual role in cancer necessitates a nuanced understanding for therapeutic strategies.
- Targeting DDX3 and its associated pathways offers potential for novel cancer treatments.
- Further research into DDX3 mechanisms can advance personalized and precision medicine.
More Related Videos
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Abnormal Proliferation
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

